SATB2 and cancer: To investigate the clinical relevance of the expression of miR-449a, miR-34a and their target gene SATB2, we detected their expression levels by qPCR in 50 paired human colorectal normal and cancer tissues which included 10 stage I, 15 stage II, 10 stage III and 15 stage IV samples, respectively (Supplementary Table S2).